Thomas Diraimondo

Chief Scientific Officer, Janux Therapeutics, Inc.

Companies

Janux Therapeutics, Inc.Chief Scientific Officer Jan 3, 2024 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Janux Therapeutics, Inc. JANX155,825 shares²$2.7M at $17.32Jan 2, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Jan 2, 2026Granted 31,400 shares of Janux Therapeutics, Inc.²
Jan 2, 2026Sold 2,505 shares at $13.73 of Janux Therapeutics, Inc.²
Jan 2, 2025Granted 24,000 shares of Janux Therapeutics, Inc.³
Sep 27, 2024Sold 675 shares at $47.22 of Janux Therapeutics, Inc.⁴
Sep 27, 2024Sold 4,325 shares at $46.21 of Janux Therapeutics, Inc.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARJanux Therapeutics, Inc., Chief Scientific Officer
2
SEC EDGARJanux Therapeutics, Inc. shares after the filing of Jan 2, 2026
3
SEC EDGARForm 4 filed Jan 3, 2025
4
SEC EDGARForm 4 filed Sep 27, 2024